July 12, 2022
mayank
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Guidance
NAV Growth : Rs 19.5300
NAV IDCW : Rs 16.3200
Suitable For Which Investors ?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy :
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund Manager :
— Dharmesh Kakkad
Education : Mr. kakkad is B.com., CA & CFA.
Experience : He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Investment Details
| Min. Investment (Rs) | 5,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 100 |
| Min. No of Cheques | 6 |
| Min. Withdrawal (Rs) | 1 |
| Min. Balance (Rs) | — |
| Lock-in Period | Not Applicable |
| Exit Load | 1% for redemption within 15 days |
Basic Details
| Fund House: | ICICI Prudential Mutual Fund |
| Launch Date: | 13-Jul-18 |
| Return Since Launch: | 18.23% |
| Benchmark: | S&P BSE Healthcare TRI |
| Riskometer: | Very High |
| Type: | Open-ended |
| % Assets: | Rs 2,417 Cr |
| (As on 30-Jun-2022) | |
| Expense: | 1.23% |
| (As on 31-May-2022) | |
| Risk Grade: | — |
| Return Grade: | — |
| Turnover: | 49.00% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Guidance Trailing Returns (%)
| YTD | 1-Day | 1-W | 1-M | 3-M | 6-M | 1-Y | 3-Y | 5-Y | 7-Y | 10-Y | |
| ICICI Pru Pharma Healthcare And Diagnostics (P.H.D) Fund Direct-G | -10.74 | 0.67 | 2.79 | 1.45 | -7.22 | -9.42 | -9.28 | 25.77 | — | — | — |
| S&P BSE Healthcare TRI | -14.58 | 0.72 | 2.71 | 1.35 | -10.68 | -12.64 | -13.17 | 21.05 | — | — | — |
| Equity: Sectoral-Pharma | -12.69 | 0.58 | 2.55 | 1.97 | -8.75 | -10.92 | -9.84 | 24.81 | — | — | — |
| Rank within category | 2 | 3 | 3 | 9 | 1 | 2 | 5 | 3 | — | — | — |
| Number of funds in category | 11 | 11 | 11 | 11 | 11 | 11 | 10 | 9 | 4 | 3 | 0 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Guidance Peer Comparison
| Fund name | Rating | Launch Date | 1-Year Return | 3-Year Return | 5-Year Return | Expense Ratio | Assets (Cr) |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | Unrated | Jul-18 | -9.28 | 25.77 | — | 1.23% | 2,417 |
| Nippon India Pharma Fund | Unrated | Jan-13 | -12.18 | 24.81 | 16.24 | 1.04% | 4,400 |
| Mirae Asset Healthcare Fund | Unrated | Jul-18 | -7.39 | 29.55 | — | 0.64% | 1,629 |
| SBI Healthcare Opportunities Fund | Unrated | Jan-13 | -10.62 | 24.99 | 11.27 | 1.07% | 1,590 |
| DSP Healthcare Fund | Unrated | Nov-18 | -8.82 | 28.62 | — | 0.82% | 1,120 |
Portfolio Analysis
| Number of Stocks | 30 |
| Top 10 Stocks (%) | 58.43 |
| Top 5 Stocks (%) | 39.86 |
| Top 3 Sectors (%) | 93.41 |
| Portfolio P/B Ratio | 3.1 |
| Portfolio P/E Ratio | 26.56 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 33,712 | 53,550 |
| Giant (%) | 15.2 | 19.21 |
| Large (%) | 30.13 | 38.32 |
| Mid (%) | 40.21 | 35.43 |
| Small (%) | 13.65 | 6.95 |
| Tiny (%) | 0.81 | 0.7 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Guidance by Chanakya :
Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Apply Online :
Stock Research Reports :
https://www.analysislibrary.com/
NFO Guidance :
https://sahifund.com/category/nfos/
Chanakya’s Mutual Fund Guidance on Youtube
https://www.youtube.com/c/ChanakyaNiPothi
Join Chanakya’s Telegram Channel @
https://t.me/chanakyanipothi